Adjunctive Pascolizumab in Rifampicin-Susceptible Pulmonary Tuberculosis: Proof-of-Concept, Partially-Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial

by Paton, Nicholas I., Gurumurthy, Meera, Lu, Qingshu, Leek, Francesca, Kwan, Philip, Koh, Hiromi W. L., Molton, James, Mortera, Lalaine, Naval, Sullian, Abu Bakar, Zamzurina, Pang, Yong-Kek, Lum, Lionel, Lim, Tow Keang, Cross, Gail B., Lekurwale, Ganesh, Choi, Hyungwon, Au, Veonice, Connolly, John, Hibberd, Martin, Green, Justin A., Team, Pascolizumab TB Trial
Published 2024